General Information of the Compound
| Compound ID |
CP0317848
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
BMS-908662
Show/Hide
|
||||||||||||||||||
| Synonyms |
870603-16-0
BMS 908662
BMS-908662
BMS-908662 free base
BMS908662
CHEMBL3545027
Carbamic acid, (5-(2-(5-chloro-2-methylphenyl)-2,3-dihydro-1-hydro
Carbamic acid, N-(6-(2-(5-chloro-2-methylphenyl)-2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)-, methyl ester
DB12854
EXEL-2819
GTPL7968
Methyl (5-(2-(5-chloro-2-methyl
Methyl (5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)carbamate, (+/-)-
SCHEMBL10049428
SCHEMBL20299316
XL 281
XL-281
XL281
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H19ClN4O4
|
||||||||||||||||||
| Molecular Weight |
462.893
|
||||||||||||||||||
| Canonical SMILES |
COC(=O)Nc1nc2cc(ccc2[nH]1)C1(O)N(C(=O)c2ccccc12)c1cc(Cl)ccc1C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H19ClN4O4/c1-13-7-9-15(25)12-20(13)29-21(30)16-5-3-4-6-17(16)24(29,32)14-8-10-18-19(11-14)27-22(26-18)28-23(31)33-2/h3-12,32H,1-2H3,(H2,26,27,28,31)
Show/Hide
|
||||||||||||||||||
| InChIKey |
MMNNTJYFHUDSKL-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
870603-16-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Clinical Information about the Compound